Prevention and management of postpartum hemorrhage

American Family Physician

Volumn 75, Issue 6, 2007, Pages 875-882

  Anderson, Janice M ^a   Etches, Duncan ^b  

^a Forbes Family Medicine Residency Program   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CARBOPROST; CARBOPROST TROMETAMOL; ERGOMETRINE; ERGOT ALKALOID; METHYLERGOMETRINE; METHYLERGOMETRINE MALEATE; MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

BLOOD CLOTTING DISORDER; DIARRHEA; DRUG CONTRAINDICATION; DRUG MECHANISM; FEVER; FLUSHING; HEADACHE; HUMAN; HYPERTENSION; NAUSEA; PLACENTAL DELIVERY; POSTPARTUM HEMORRHAGE; RETAINED PLACENTA; REVIEW; SIDE EFFECT; UTERINE ATONY; UTERUS INVERSION; UTERUS RUPTURE; VOMITING;

FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 33947248470     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. The Prevention and Management of Postpartum Haemorrhage: Report of Technical Working Group, Geneva 3-6 July 1989. Geneva: World Health Organization, 1990.
2. Elbourne DR, Prendiville WJ, Carroli G, Wood J, McDonald S. Prophylactic use of oxytocin in the third stage of labour. Cochrane Database Syst Rev 2001;(4):CD001808.
3. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or = 500 mL) and severe (> or = 1000 mL) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2004;115:166-72.
4. Magann EF, Evans S, Chauhan SP, Lanneau G, Fisk AD, Morrison JC. The length of the third stage of labor and the risk of postpartum hemorrhage. Obstet Gynecol 2005;105:290-3.
5. Corwin EJ, Murray-Kolb LE, Beard JL. Low hemoglobin level is a risk factor for postpartum depression. J Nutr 2003;133:4139-42.
6. Ekeroma AJ, Ansari A, Stirrat GM. Blood transfusion in obstetrics and gynaecology. Br J Obstet Gynaecol 1997;104:278-84.
7. Willis CE, Livingstone V. Infant insufficient milk syndrome associated with maternal postpartum hemorrhage. J Hum Lact 1995;11:123-6.
8. Sert M, Tetiker T, Kirim S, Kocak M. Clinical report of 28 patients with Sheehan's syndrome. Endocr J 2003;50:297-301.
9. Reyal F, Deffarges J, Luton D, Blot P, Oury JF, Sibony O. Severe post-partum hemorrhage: descriptive study at the Robert-Debre Hospital maternity ward [French]. J Gynecol Obstet Biol Reprod (Paris) 2002;31:358-64.
10. Gabbe SG, Niebyl JR, Simpson JL. Obstetrics: Normal and Problem Pregnancies. 4th ed. New York: Churchill Livingstone, 2002.
11. Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;77:69-76.
12. Stones RW, Paterson CM, Saunders NJ. Risk factors for major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol 1993;48:15-8.
13. Sherman SJ, Greenspoon JS, Nelson JM, Paul RH. Identifying the obstetric patient at high risk of multiple-unit blood transfusions. J Reprod Med 1992;37:649-52.
14. Malhotra M, Sharma JB, Batra S, Sharma S, Murthy NS, Arora R. Maternal and perinatal outcome in varying degrees of anemia. Int J Gynaecol Obstet 2002;79:93-100.
15. Singla AK, Lapinski RH, Berkowitz RL, Saphier CJ. Are women who are Jehovah's Witnesses at risk of maternal death? Am J Obstet Gynecol 2001;185:893-5.
16. Ceriani Cernadas JM, Carroli G, Pellegrini L, Otano L, Ferreira M, Ricci C, et al. The effect of timing of cord clamping on neonatal venous hematocrit values and clinical outcome at term: a randomized, controlled trial. Pediatrics 2006;117:e779-86.
17. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev 2000;(3):CD000007.
18. Jackson KW Jr, Allbert JR, Schemmer GK, Elliot M, Humphrey A, Taylor J. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol 2001;185:873-7.
19. Rizvi F, Mackey R, Barrett T, McKenna P, Geary M. Successful reduction of massive postpartum haemorrhage by use of guidelines and staff education. BJOG 2004;111:495-8.
20. Lalonde A, Daviss BA, Acosta A, Herschderfer K. Postpartum hemorrhage today: ICM/FIGO initiative 2004-2006. Int J Gynaecol Obstet 2006;94:243-53.
21. Chaparro CM, Neufeld LM, Tena Alavez G, Eguia-Liz Cedillo R, Dewey KG. Effect of timing of umbilical cord clamping on iron status in Mexican infants: a randomised controlled trial. Lancet 2006;367:1997-2004.
22. Rabe H, Reynolds G, Diaz-Rossello J. Early versus delayed umbilical cord clamping in preterm infants. Cochrane Database Syst Rev 2004(4):CD003248.
23. van Rheenen P, Brabin BJ. Late umbilical cord-clamping as an intervention for reducing iron deficiency anaemia in term infants in developing and industrialised countries: a systematic review. Ann Trop Paediatr 2004;24:3-16.
24. Nordstrom L, Fogelstam K, Fridman G, Larsson A, Rydhstroem H. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol 1997;104:781-6.
25. McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev 2004;(1):CD000201.
26. Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev 2004;(1):CD000494.
27. Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik V, Bellad MB, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet 2006;368:1248-53.
28. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2003;(1):CD003249.
29. Anderson J, Etches D, Smith D. Postpartum hemorrhage. In: Baxley E. Advanced Life Support in Obstetrics course syllabus. 4th ed. Leawood, Kan.: American Academy of Family Physicians, 2001.
30. Blanks AM, Thornton S. The role of oxytocin in parturition. BJOG 2003;110(suppl 20):46-51.
31. Soriano D, Dulitzki M, Schiff E, Barkai G, Mashiach S, Seidman DS. A prospective cohort study of oxytocin plus ergometrine compared with oxytocin alone for prevention of postpartum haemorrhage. Br J Obstet Gynaecol 1996;103:1068-73.
32. De Costa C. St Anthony's fire and living ligatures: a short history of ergometrine. Lancet 2002;359:1768-70.
33. Mosby's Drug Consult 2005. St. Louis, Mo.: Mosby, 2005.
34. Lamont RF, Morgan DJ, Logue M, Gordon H. A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage. Prostaglandins Other Lipid Mediat 2001;66:203-10.
35. Oleen MA, Mariano JP. Controlling refractory atonic postpartum hemorrhage with Hemabate sterile solution. Am J Obstet Gynecol 1990;162:205-8.
36. Caliskan E, Dilbaz B, Meydanli MM, Ozturk N, Narin MA, Haberal A. Oral misoprostol for the third stage of labor: a randomized controlled trial. Obstet Gynecol 2003;101(5 pt 1):921-8.
37. Hofmeyr GJ, Walraven G, Gulmezoglu AM, Maholwana B, Alfirevic Z, Villar J. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG 2005;112:547-53.
38. Chong YS, Chua S, Shen L, Arulkumaran S. Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery. Eur J Obstet Gynecol Reprod Biol 2004;113:191-8.
39. Lumbiganon P, Villar J, Piaggio G, Gulmezoglu AM, Adetoro L, Carroli G. Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour. BJOG 2002;109:1222-6.
40. Carroli G, Belizan J. Episiotomy for vaginal birth. Cochrane Database Syst Rev 1999;(3):CD000081.
41. Benrubi G, Neuman C, Nuss RC, Thompson RJ. Vulvar and vaginal hematomas: a retrospective study of conservative versus operative management. South Med J 1987;80:991-4.
42. Baskett TF. Acute uterine inversion: a review of 40 cases. J Obstet Gynaecol Can 2002;24:953-6.
43. Watson P, Besch N, Bowes WA Jr. Management of acute and subacute puerperal inversion of the uterus. Obstet Gynecol 1980;55:12-6.
44. Chauhan SP, Martin JN Jr, Henrichs CE, Morrison JC, Magann EF. Maternal and perinatal complications with uterine rupture in 142,075 patients who attempted vaginal birth after cesarean delivery: a review of the literature. Am J Obstet Gynecol 2003;189:408-17.
45. Guise JM, McDonagh MS, Osterweil P, Nygren P, Chan BK, Helfand M. Systematic review of the incidence and consequences of uterine rupture in women with previous caesarean section. BMJ 2004;329:19-25.
46. Landon MB, Hauth JC, Leveno KJ, Spong CY, Leindecker S, Varner MW, et al.; for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 2004;351:2581-9.
47. ACOG practice bulletin #54: vaginal birth after previous cesarean. Obstet Gynecol 2004;104:203-12.
48. ACOG committee opinion #342: induction of labor for vaginal birth after cesarean delivery. Obstet Gynecol 2006;108:465-8.
49. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192:1458-61.
50. Weeks AD, Mirembe FM. The retained placenta - new insights into an old problem. Eur J Obstet Gynecol Reprod Biol 2002;102:109-10.
51. Carroli G, Bergel E. Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev 2001;(4):CD001337.
52. Mussalli GM, Shah J, Berck DJ, Elimian A, Tejani N, Manning FA. Placenta accreta and methotrexate therapy: three case reports. J Perinatol 2000;20:331-4.
53. O'Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 1996;175:1632-8.
54. Alamia V Jr, Meyer BA. Peripartum hemorrhage. Obstet Gynecol Clin North Am 1999;26:385-98.
55. Pritchard JA. Fetal death in utero. Obstet Gynecol 1959;14:573-80.
56. Price G, Kaplan J, Skowronski G. Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient. Br J Anaesth 2004;93:298-300.
57. Magann EF, Lanneau GS. Third stage of labor. Obstet Gynecol Clin North Am 2005;32:323-32, x-xi.